Effect of Gamma-Hydroxybutyric Acid on Lipid Peroxidation and Tissue Lactate Level in Experimental Head Trauma

Journal of Trauma - Injury, Infection and Critical Care

Volumn 56, Issue 3, 2004, Pages 585-590

  Yosunkaya, Alper ^a   Ak, Ahmet ^a   Barişkaner, Hülagü ^a   Üstün, Mehmet Erkan ^a   Tuncer, Sema ^a   Gürbilek, Mehmet ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Gamma hydroxybutyric acid; Head trauma; Lactate; Malondialdehyde

Indexed keywords

4 HYDROXYBUTYRIC ACID; LACTIC ACID; LIPID PEROXIDE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CRANIECTOMY; ELECTROENCEPHALOGRAM; FEMALE; HEAD INJURY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECTUM TEMPERATURE;

EID: 1942476684     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000058119.60074.25     Document Type: Article

References (54)

1. Clifton GL, Robertson CS, Grossman RG, et al. The metabolic response to severe head injury. J Neurosurg. 1984;60:687-696.
2. Rabow L, DeSalles AF, Becker DP, et al. CSF brain creatine kinase levels and lactic acidosis in severe head injury. J Neurosurg. 1986; 65:625-629.
3. Shapira Y, Yadid G, Cotev S, et al. Accumulation of calcium in the brain following head trauma. Neurol Res. 1989;11:169-172.
4. Bullock R, Lyeth BG, Muizelaar JP. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery. 1999;45:207-217.
5. Bullock R, Zauner A, Woodward JJ, et al. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg. 1998;89:507-518.
6. Ikeda Y, Long DM. The molecular basis of brain injury and brain edema: the role of oxygen free radicals. Neurosurgery. 1990;27:1-11.
7. Kiwak KJ, Moskowitz MA, Levine L. Leukotriene production in gerbil brain after ischemic insult, subarachnoid hemorrhage, and concussive injury. J Neurosurg. 1985;62:865-869.
8. DeSalles AF, Muizelaar JP, Young HF. Hyperglycemia cerebrospinal fluid lactic acidosis and cerebral blood flow in severely head injured patients. Neurosurgery. 1987;21:45-50.
9. Peters T. Calcium in physiological and pathological cell function. Eur Neurol. 1986;25:27-44.
10. Triggle DJ. Calcium antagonists: history and perspective. Stroke. 1990;21:49-58.
11. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci. 1990; 15:129-135.
12. Callaway JK, Beart PM, Jarrott B. A reliable procedure for comparison of antioxidants in rat brain homogenates. J Pharmacol Toxicol Methods. 1998;39:155-162.
13. Meerson FZ, Dolgikh VT. Prevention of heart damage of sodium oxybutyrate in terminal states caused by acute blood loss. Kardiologiia. 1982;22:38-44.
14. Plotnikov MB, Kobzeva EA, Plotnikova TM. Antioxidant effects of antihypoxic drugs in cerebral ischemia. Biull Eksp Biol Med. 1992; 113:504-506.
15. Sherman IA, Saibil FG, Janossy TI. Gamma-hydroxybutyrate mediated protection of liver function after long-term hypothermic storage. Transplantation. 1994;57:8-11.
16. Petrin IN, Dolgikh VT, Krolevets IP. The use of sodium gamma-oxybutyrate and gutimine for decreasing metabolic disorders in the heart, caused by exotoxic shock in acetic acid poisoning. Vopr Med Khim. 1993;39:36-39.
17. Lopatin AF, Riabtseva EG, Riabova VV, et al. Effect of sodium oxybutyrate on metabolic indices in ischemic hypoxia of muscle tissue. Farmakol Toksikol. 1984;47:53-55.
18. Feeney DM, Boyeson MG, Linn RT, et al. Responses to cortical injury: I-methodology and local effects of contusions in the rat. Brain Res. 1981;211:67-77.
19. Ogun CO, Ustun ME, Duman A, et al. Correlation between tissue lactate levels and electroencephalogram in evaluating the severity of experimental head trauma. Crit Care Med. 2002;30:2123-2128.
20. Ustun ME, Gurbilek M, Ak A, et al. Effects of magnesium sulfate on tissue lactate and malondialdehyde levels in experimental head trauma. Intensive Care Med. 2001;27:264-268.
21. Chang YS, Park WS, Lee M, et al. Effect of hyperglycemia on brain cell membrane function and energy metabolism during hypoxia-ischemia in newborn piglets. Brain Res. 1998;798:271-280.
22. Stover JF, Morganti-Kosmann MC, Lenzlinger PM, et al. Glutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patients. J Neurotrauma. 1999;16:135-142.
23. Muir KW, Less KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 1995;26:503-513.
24. Koura SS, Doppenberg EM, Marmarou A, et al. Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl. 1998;71:44-46.
25. Katayama Y, Fukuchi T, Kee AM, et al. Effect of hyperglycemia on pyruvate dehydrogenase activity and energy metabolites during ischemia and reperfusion in geril brain. Brain Res. 1998;788:302-304.
26. Rolfsen ML, Dawis WR. Cerebral function and preservation during cardiac arrest. Crit Care Med. 1989;17:283-290.
27. LeBlanc MH, Vig V, Randhawa T, et al. Use of polyethylene glycol-bound superoxide dismutase, polyethyleneglycol-bound catalase, and nimodipine to prevent hypoxic ischemic injury to the brain of newborn pigs. Crit Care Med. 1993;4:252-259.
28. Chacon E, Acosta D. Mitochondrial regulation of superoxide by calcium: an alternate mechanism for the cardiotoxicity of doxorubicin. Toxicol Appl Pharmacol. 1991;107:117-128.
29. Ikeda K, Nagashima T, Wu S, et al. The role of calcium ion in anoxia/reoxygenation damage of cultured brain capillary endothelial cells. Acta Neurochir Suppl. 1997;70:4-7.
30. Henderson LM, Chappell JB, Jones OTG. Internal pH changes associated with the activity of NADPH oxidase of human neutrophils. Biochem J. 1988;251:563-567.
31. Southard JH, Marsh DC, McAnulty JF, et al. Oxygen-derived free radical damage in organ preservation: activity of superoxide dismutase and xanthine oxidase. Surgery. 1987;101:566-570.
32. Palmer C, Roberts RL, Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke. 1994;24:1039-1045.
33. Sims NR, Anderson MF, Hobbs LM, et al. Impairment of brain mitochondrial function by hydrogen peroxide. Brain Res Mol. 2000; 77:176-184.
34. Marino PL. The ICU Book. 2nd ed. Baltimore: Williams & Wilkins; 1997:32-50.
35. Dosmagambetova R. Prevention of stress-induced disturbances of contractility in non-ischemic regions of the heart in myocardial infarction by gamma-hydroxybutyric acid. Biull Eksp Biol Med. 1983;96:28-30.
36. Lavyne M, Hariri R, Tankosic T, et al. Effect of low dose gamma-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained, awake rat. Neurosurgery. 1983;12:430-434.
37. MacMillan VA. The effects of gamma-hydroxybutyrate and gamma-butyrolactone upon the energy metabolism of the normoxic and hypoxic rat brain. Brain Res. 1978;146:117-187.
38. Mamelak M. Gammahydroxybutyrate: an endogenous regulator of energy metabolism. Neurosci Biobehav Rev. 1989;13:187-198.
39. Erdmann W, Faithfull N. The disturbance of cellular oxygen supply in the post-hypoxic period. In: Waugiuer A, Borgers M, Amery WK, eds. Protection of Tissues Against Hypoxia. Amsterdam: Elsevier Biomedical Press; 1982:183-197.
40. Smith A, Lee N. Pharmacology of dynorphin. Ann Rev Pharmacol Toxicol. 1988;28:123-140.
41. Hochachka P. Metabolic arrest. Intensive Care Med. 1986;12:127-133.
42. Dreher W, Kuhn B, Gyngell ML, et al. Temporal and regional changes during focal ischemia in rat brain studied by proton spectroscopic imaging and quantitative diffusion NMR imaging. Magn Reson Med. 1998;39:878-888.
43. Vagnozzi R, Marmarou A, Tavazzi B, et al. Changes of cerebral energy metabolism and lipid peroxidation in rats leading to mitochondrial dysfunction after diffuse brain injury. J Neurotrauma. 1999;16:903-913.
44. Barut S, Canbolat A, Bilge T, et al. Lipid peroxidation in experimental spinal cord injury: time-level relationship. Neurosurg Rev. 1993;16:53-59.
45. Manina A, Kucherenko R, Melnikova L, et al. Subcellular reaction of the brain to hypoxia. Arkhiv Anatomii Gistologii Embriologi. 1978;75:39-46.
46. Li J, Stokes SA, Woeckener A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med. 1998;31:729-736.
47. Hutchins D, Rayevsky K, Sharman D. The effect of sodium gammahydroxybutyrate on the metabolism of dopamine in the brain. Br J Pharmacol. 1972;46:409-415.
48. Lin M, Chern Y, Wang H, et al. Effects of gamma-hydroxybutyric acid on metabolic respiratory and vasomotor activities and body temperature in rats. J Pharmacol Exp Ther. 1979;211:167-170.
49. Shumate J, Snead O. Plasma and central nervous system kinetics of gammahydroxybutyrate. Res Commun Chem Pathol Pharmacol. 1979;25:241-256.
50. Snead O. Gammahydroxybutyrate in the monkey: I-electroencephalographic behavioural and pharmacokinetic studies. Neurology. 1978;28:636-648.
51. Novikov VE, Sharov A. The effect of GABA-ergic agents on oxidative phosphorylation in the brain mitochondria in traumatic edema. Farmakol Toksikol. 1991;54:44-46.
52. Verier A, Jomin M, Lozes G, et al. Post-traumatic cerebral edema: physiopathology and treatment. Sem Hop. 1984;60:673-677.
53. Tommasino C, Picozzi P. Mild hypothermia. J Neurosurg Sci. 1998; 42:37-38.
54. Jiang J, Zhu C, Lu Y, et al. The effects of mild hypothermia on patients with severe traumatic brain injury. Neurosci Res. 1998; 32:103-107.